Company Overview
Nano Labs Ltd operates as a fabless integrated circuit design company and product solution provider serving markets across the People's Republic of China, Hong Kong, Singapore, the United States, and internationally, with a primary focus on developing computing chips and application-specific integrated circuit chips. The company functions within the Technology sector, specifically the Semiconductors industry, where it specializes in the architectural design of semiconductor components rather than manufacturing them, a model that capitalizes on third-party fabrication capacity to deliver specialized hardware solutions. At a market capitalization of $68.89M, Nano Labs Ltd employs 88 individuals and reported annual revenue of $24.14M based on trailing twelve-month figures, indicating a mid-cap enterprise with a relatively lean operational footprint. These valuation and revenue metrics suggest the company occupies a niche position within the broader semiconductor landscape, likely targeting specialized computing applications where high performance per watt or specific algorithmic acceleration is required, though the current scale reflects the high capital intensity and development costs typical of the integrated circuit design phase.
Financial Health
The company reported trailing twelve-month revenue of $24.14M against a net income of $-63,007,848 and an EBITDA of $-55,002,272, revealing a significant structural cost burden where operating expenses and cost of goods sold far exceed gross revenue generation. The reported free cash flow of $-390,043,872 highlights substantial cash outflows from operations and investing activities, indicating limited immediate financial flexibility to fund growth without external capital injection or significant restructuring. Margin analysis shows a gross margin of 48.8%, which suggests favorable pricing power or cost control on the production side, yet this is heavily eroded by an operating margin of -459.2% and a profit margin of -261.0%, pointing to aggressive spending in research, development, or general administrative overheads that outweigh total sales. On the liability side, the company holds $365.94M in cash against $215.84M in debt, resulting in a debt-to-equity ratio of 34.87, which indicates a highly leveraged balance sheet despite the ample cash on hand, likely reflecting historical financing structures or share-based compensation dilution affecting equity. The current ratio stands at 1.81, suggesting that the company maintains adequate short-term liquidity to cover its immediate obligations without default risk in the near term. Furthermore, the return on equity is -24.5% and the return on assets is -4.5%, metrics that reveal management is currently generating negative returns on the capital invested in the business, a common but critical feature for pre-revenue or early-stage semiconductor firms attempting to scale technology before achieving profitability.
Valuation Assessment
The trailing P/E ratio and forward P/E ratio are both listed as N/A, implying that earnings per share is currently negative and therefore traditional price-to-earnings multiples cannot be calculated to assess valuation relative to profitability. The price-to-book ratio is 0.77, indicating that the market values the company's equity at a discount to its book value, which can signal undervaluation or market skepticism regarding the quality of the company's assets and future earnings potential. Alternative valuation metrics such as the price-to-sales ratio of 2.85 and an EV/EBITDA of 1.52 provide perspective, suggesting the market is pricing the company based on revenue multiples and enterprise value relative to earnings before interest, taxes, depreciation, and amortization, despite the lack of positive earnings. The stock has traded between a 52-week high of $31.48 and a 52-week low of $2.74, a massive range that underscores the extreme volatility and speculative nature of the share price relative to its historical trading bands. With a beta of 6.30, the stock exhibits extreme price volatility, moving significantly more than the broader market and exposing investors to heightened risk during periods of market turbulence or sector-wide adjustments.
Growth & Income
Nano Labs Ltd experienced a revenue growth rate of -66.5% year over year, while earnings growth is N/A due to negative earnings, indicating that the company is currently contracting in terms of top-line sales rather than expanding its market share. Since the company does not pay a dividend, the dividend yield is N/A and the payout ratio is 0.0%, meaning the company retains all available cash to fund its operations, research initiatives, or debt reduction rather than distributing income to shareholders. The absence of dividend payments combined with negative earnings growth suggests the company is in a phase of consolidation or restructuring rather than a mature growth phase focused on shareholder distribution. Overall, the growth and income profile is characterized by significant revenue contraction, negative cash flow generation, and a complete reliance on internal capital reserves or external financing to sustain operations without providing current income to investors.